期刊
NATURE REVIEWS NEPHROLOGY
卷 11, 期 2, 页码 68-69出版社
NATURE PUBLISHING GROUP
DOI: 10.1038/nrneph.2014.238
关键词
-
In 2014, key studies in the field of diabetic nephropathy highlighted the importance of albuminuria as a predictor of cardiovascular risk and showed that the incidence of renal and cardiovascular complications is decreasing. Promising efficacy data were obtained with atrasentan, whereas a trial of bardoxolone methyl led to safety concerns.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据